| Bioactivity | (+)-Dihydrocalanolide A (DHCal A; NSC 678323) is an orally active nonnucleoside inhibitor of Reverse Transcriptase. (+)-Dihydrocalanolide A can be used to HIV infection research[1]. |
| In Vivo | (+)-Dihydrocalanolide A (25 mg/kg; p.o.; single dose) 具有良好的药代动力学参数，在 CD2F1 小鼠中的口服生物利用度为 64%[1]。 |
| Name | (+)-Dihydrocalanolide A |
| CAS | 183904-53-2 |
| Formula | C22H28O5 |
| Molar Mass | 372.45 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Newman RA, et al. Pharmaceutical properties of related calanolide compounds with activity against human immunodeficiency virus. J Pharm Sci. 1998 Sep;87(9):1077-80. |
(+)-Dihydrocalanolide A
CAS: 183904-53-2 F: C22H28O5 W: 372.45
(+)-Dihydrocalanolide A (DHCal A; NSC 678323) is an orally active nonnucleoside inhibitor of Reverse Transcriptase. (+)-
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.